Phase 2 Study Of VLA15, A Vaccine Candidate Against Lyme Borreliosis, In A Healthy Pediatric And Adult Study Population
Clinical trial NCT04801420 · COMPLETED
Trial details
- NCT number
- NCT04801420
- Sponsor
- Pfizer
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-08
- Primary completion
- 2022-03-25
- Enrollment
- 625
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.